|Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 548 active entries
Lochhamer Str. 29a
Phone: +49 89 4431 2453
Fax: +49 89 8955 7281
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
RNA interference (RNAi) has become the standard tool for sequence-specific gene knockdown in laboratory research. After initial hype and the hope that RNAi would develop into a potent novel strategy for the therapy of many diseases, it became clear that several problems associated with the technology remain unsolved. One of these challenges is off-target effects, i.e. most siRNAs not only target their complementary on-target gene but also deregulate an unknown number of off-target genes. These off-target effects are sequence-specific and intrinsic to each siRNA. Even though some progress was made to reduce off-target effects, no RNAi reagent so far provides a satisfactory protection against off-target effects.
Our next-generation RNAi reagents, called siPOOLs, are complex pools of 30 selected siRNAs against the target gene. Thus,
- siPOOLs are sufficiently complex to reliably dilute the off-target effects specific to each individual siRNA molecule below detection limit, and
- siPOOLs are a defined composition of siRNAs, leading to highly efficient and reliable gene knockdown results and clear phenotypic data.
Last update of this entry: March 16, 2015